Trials / Completed
CompletedNCT00077688
TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium
A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(TM) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) in Patients With Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma of the Urothelium
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (planned)
- Sponsor
- Achieve Life Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase 2B, multicenter study evaluating the safety and efficacy of weekly TOCOSOL Paclitaxel in taxane-naive patients receiving second line chemotherapy for metastatic or locally advanced, unresectable transitional cell carcinoma of the urothelium
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TOCOSOL Paclitaxel |
Timeline
- Start date
- 2003-11-01
- Completion
- 2007-09-01
- First posted
- 2004-02-16
- Last updated
- 2009-06-04
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00077688. Inclusion in this directory is not an endorsement.